Intervention
Clinical Observation
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 8 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
8 shownSchedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate CancerNCT06200103 · 2024-05-03
SUSPENDEDWhite Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CANCT04519879 · 2021-05-10
SUSPENDEDMulticenter Study of Impulse Oscillometry in ChineseNCT03467880 · 2016-09-01
UNKNOWNCrizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)NCT02201992 · 2015-03-23
ACTIVE_NOT_RECRUITINGErlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)NCT02193282 · 2015-02-11
ACTIVE_NOT_RECRUITINGGenetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738 · 2014-09-26
ACTIVE_NOT_RECRUITINGSurgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung CancerNCT01725165 · 2012-11-28
COMPLETEDBicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate CancerNCT01251861 · 2011-03-17
COMPLETEDCommon conditions
Recurrent Prostate Carcinoma2Stage IB Lung Non-Small Cell Carcinoma AJCC v72Stage II Lung Non-Small Cell Cancer AJCC v72Stage IIIA Lung Non-Small Cell Cancer AJCC v72ALK Gene Rearrangement1ALK Gene Translocation1ALK Positive1Asthma1Castration-Resistant Prostate Carcinoma1Chronic Obstructive Pulmonary Disease1Healthy Subjects1Interstitial Lung Disease1Lung Non-Squamous Non-Small Cell Carcinoma1Prostate Adenocarcinoma1PSA Failure1PSA Progression1Recurrent Lung Non-Small Cell Carcinoma1Stage I Prostate Cancer AJCC v71Stage I Prostate Cancer AJCC v81Stage IB Non-Small Cell Lung Carcinoma AJCC v71Stage II Non-Small Cell Lung Cancer AJCC v71Stage IIA Lung Cancer AJCC v81Stage IIA Lung Non-Small Cell Carcinoma AJCC v71Stage IIA Non-Small Cell Lung Carcinoma AJCC v71Stage IIA Prostate Cancer AJCC v71
Leading sponsors
Trial status mix
ACTIVE_NOT_RECRUITING3
COMPLETED2
SUSPENDED2
UNKNOWN1
Phase mix
PHASE24
PHASE32
NA1
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.